Early non-motor symptoms such as mood disorders and cognitive deficits are increasingly recognised in Parkinson's disease (PD). They may precede the characteristic motor symptomatology caused by dopamine (DA) neuronal loss in the substantia nigra pars compacta (SNc). It is well known that striatal cholinergic interneurons (ChIs) are emerging as key regulators of PD motor symptom, however, their involvement in the cognitive and affective alterations occurring in the premotor phase of PD is poorly understood. We used optogenetic photoinhibition of striatal ChIs in mice with mild nigrostriatal 6-hydroxydopamine (6-OHDA) lesions and assessed their role in anxiety-like behaviour in the elevated plus maze, social memory recognition of a congener and visuospatial object recognition. In transgenic mice specifically expressing halorhodopsin (eNpHR) in cholinergic neurons, striatal ChIs photoinhibition reduced the anxiety-like behaviour and reversed social and spatial short-term memory impairment induced by moderate DA depletion (e.g., 50% loss of tyrosine hydroxylase TH-positive neurons in the SNc). Systemic injection of telenzepine (0.3 mg/kg), a preferential M1 muscarinic cholinergic receptors antagonist, improved anxiety-like behaviour, social memory recognition but not spatial memory deficits. Our results suggest that dysfunction of the striatal cholinergic system may play a role in the short-term cognitive and emotional deficits of partially DA-depleted mice. Blocking cholinergic activity with M1 muscarinic receptor antagonists may represent a possible therapeutic target, although not exclusive, to modulate these early non-motor deficits.
| INTRODUCTION
Although Parkinson's disease (PD) has traditionally been viewed as a motor disorder, caused by the progressive loss of dopaminergic (DA) neurons in the substantia nigra pars compacta (SNc; Obeso et al., 2000) , other symptoms predate for many years the appearance of motor ones including depression, anxiety, mood fluctuations, sleep behaviour disorder, olfactory deficit, and cognitive impairment (Chaudhuri, Healy, & Schapira, 2006; Chaudhuri & Odin, 2010; Chaudhuri, Odin, Antonini, & MartinezMartin, 2011) . These non-motor symptoms in PD represent one of the major challenge faced in the management of PD because it is underdiagnosed and do not respond to DA therapy. Animal models represent a useful tool to better understand disease mechanisms and can be used to test new therapeutic intervention. Recently, a number of preclinical studies have reported anxiety-like responses and mild cognitive impairments in rodent models of prodromal phase of PD produced by low doses of DA neurotoxins (Lelos & Dunnett, 2011; Magen & Chesselet, 2010) . While DA depletion is the primary cause of motor impairment, the neural substrates underlying the neuropsychiatric, and cognitive deficits associated with PD are the subjects of increasing research. The appearance of non-motor symptoms of PD may result from the loss of noradrenergic, serotoninergic as well as cholinergic neurons, followed by rearrangement of neuronal networks in limbic structures such as the amygdala, hippocampus, and prefrontal cortex (Bohnen & Albin, 2011; Kish et al., 2008; O'Callaghan & Lewis 2017; Remy, Doder, Lees, Turjanski, & Brooks, 2005; Scatton, Javoy-Agid, Rouquier, Dubois, & Agid, 1983) . Dysfunction of cholinergic neurotransmission in the cortex and the basal ganglia may occur at early stages of PD consecutive to the neurodegeneration of cholinergic neurons in the nucleus basalis of Meynert (Braak et al., 2003) and/or the pedunculopontine nucleus (PPN; Hirsch, Graybiel, Duyckaerts, & Javoy-Agid, 1987; Jellinger, 1988; Pahapill & Lozano, 2000; Karachi et al., 2010) . The PPN and lateral tegmental nuclei also provide cholinergic inputs to the striatum (Dautan et al., 2014 ) that may affect striatal cholinergic signalling. Nevertheless, striatal cholinergic interneurons (ChIs) are the primary internal source for acetylcholine (ACh), the highest level of ACh in the brain. In animal models of PD, striatal ChIs activity is modulated by rewarding and aversive stimuli and play an important role in attentional, in learning and memory ,or conditioning of response to these stimuli (Apicella, 2017; Bradfield, Bertran-Gonzalez, Chieng, & Balleine, 2013; Goldberg & Reynolds, 2011; Lenz & Lobo, 2013; Lim, Kang, & McGehee, 2014) . It was recently showed that alteration of ChIs synaptic plasticity, in rats overexpressing truncated human α-synuclein in the SNc, is associated with early cognitive deficits (Tozzi et al., 2016) . We therefore questioned whether striatal ChIs could also contribute to cognitive and anxiety symptoms in a partial 6-OHDA mice model of early PD, when motor symptoms are not manifest.
Despite their low number in the striatum (1%-2%), ChIs are regarded as key regulators of basal ganglia function in normal and diseased states (Bonsi et al., 2011; Brichta, Greengard, & Flajolet, 2013; Lester, Rogers, & Blaha, 2010; Pisani, Bernardi, Ding, & Surmeier, 2007; Scarr, 2013; Threlfell & Cragg, 2011) . Their effects are mediated by muscarinic and nicotinic receptors signalling. Muscarinic receptors (M1-M5, mAChRs) are highly expressed within the striatum, particularly the M1 subtypes that are primarily expressed on medium spiny neurons (MSNs; Zhou, Wilson, & Dani, 2003; Kreitzer, 2009 ). The discovery of drugs acting on specific mAChR subtypes raised renewed interest in the modulation of striatal cholinergic signalling to alleviate basal ganglia disorders (Eskow Jaunarajs, Bonsi, Chesselet, Standaert, & Pisani, 2015; Michelle Lewis et al., 2008; Shen et al., 2015; Wess, Eglen, & Gautam, 2007) . The imbalance between ACh and DA activity in the striatum is classically considered as central to the development of motor symptoms of PD (Di Chiara, Morelli, & Consolo, 1994; Pisani et al., 2007) , although the two systems may also act in conjunction (Calabresi, Picconi, Tozzi, Ghiglieri, & Di Filippo, 2014; Parker, Lalive, & Kreitzer, 2016; Threlfell et al., 2012) . Whether the activity of the striatal cholinergic system is also affected by a mild nigrostriatal DA denervation is largely unknown.
Here, we provide evidence that partial striatal DA depletion impairs emotional and cognitive processes in mice without affecting motor activity. Optogenetic inhibition of striatal ChIs reverses these premotor symptoms. Muscarinic M1 ACh receptors appear to be involved in this effect as the selective M1 receptor antagonist telenzepine has anxiolytic properties, restores social but not visuospatial memory. These results underline the importance of ChIs in the control of cognitive and neuropsychiatric symptoms in rodent models of PD.
| MATERIALS AND METHODS

| Mice
All procedures were approved by the French National Ethics Committee (authorisation no. 00196.01) and in accordance with the recommendations of the EEC (2010/63/UE) for care and use of laboratory animals. All animals were housed in groups of 4-5 with rodent chow and water ad libitum in a temperature-controlled room (21°C) on a 12:12 hr dark-light cycle (lights on at 07:00). 
| Stereotaxic surgery
Mice were deeply anaesthetised with intraperitoneal (i.p.) injections of ketamine and xylazine (100 and 10 mg/kg respectively) in a volume of 10 ml/kg and placed on heated pad into a stereotaxic apparatus (David Kopf Instruments).
| Nigrostriatal dopaminergic lesions
eNpHR transgenic mice and C57BL/6 mice received bilateral microinjections into the striatum of low doses of 6-hydroxydopamine hydrobromide (6-OHDA, Tocris Bioscience, UK) calculated at a free-base concentration of 4 μg/μl. A solution of 1 μl/side of 6-OHDA (diluted in 0.9% sterile NaCl containing 0.02% ascorbic acid to prevent oxidation) or vehicle (0.9% NaCl in 0.02% ascorbic acid) was slowly injected into the dorsal striatum at the following coordinates: +1.0 mm AP, ±1.5 mm ML, −3.2 mm DV, according to the atlas of Paxinos and Franklin (2001) . Stereotaxic microinjections were made with a 10 μl Hamilton microsyringe, connected to an injection cannula (33 gauge, Plastics One, Roanoke, VA) by a polyethylene tubing (Tygon catheter; 0.25 mm, i.d.) and controlled by an injection pump (CMA/100; CMA/Microdialysis, Stockholm, Sweden) at a flow rate of 0.3 μl/min. At the end of injection, injector needles remained in place for three more minutes to allow for diffusion of the solution before being slowly retracted.
| Optic fibre implantation
For optogenetic experiments, eNpHR mice submitted to 6-OHDA procedure were also implanted with optical fibres during the same surgery. Optical fibres consisted of a zirconia ferrule with a 200 μm diameter and 3.0 mm long cleaved bare optic fibres (0.22 numerical aperture (Doric Lenses, Quebec, Canada). Fibres were bilaterally implanted into the striatum at the following coordinates: +0.5 mm AP, ±1.5 mm ML, −2.8 mm DV (Paxinos & Franklin, 2001 ) and affixed to the skull with superbond glue and dental cement.
All mice were given 0.06 ml of rimadyl 1/10, 0.02 ml baytril 1/10 and glucose 5% 0.3 ml after surgery to prevent infections and help alleviate pain associated with the surgical procedure. Mice were monitored daily and received glucose injections and wet laboratory chow to avoid dehydration if needed. All experiments were performed after a minimum of 10-14 days period of recovery after surgery.
| Optogenetic photoinhibition
For bilateral illumination, optical fibres were connected to the laser through a rotary joint (FRJ_1x2i_FC-2FC, Doric Lenses) that sent half of the light coming from the laser into each of the two optical fibres inserted in the mouse brain and enabled the mouse to move freely during behavioural assessments. Light was provided by a yellow laser (589 nm, 75.2 mW, continuous stimulation; Combined Dual Wavelength DPSS Laser System, Laserglow, Canada). Optical-fibre light power was measured using a power meter (PM100D, ThorLabs) connected to a photodiode power sensor (S120C, 400-1,100 nm, 50 mW, ThorLabs) and verified before and after every behavioural experiments. The intensity was calculated using the model based on direct measurements in mammalian brain tissue for predicting irradiance values developed in K. Deisseroth's laboratory and available at the webpage http://www.stanford.edu/group/dlab/cgi-bin/ graph/chart.php. Light intensity at 0.2 mm from fibre tip was calculated to be 20 mW/mm 2 (corresponding to 140 mW/ mm 2 at the fibre tip).
| Drug treatment
Telenzepine dihydrochloride hydrate was purchased from Sigma-Aldrich (St-Quentin Fallavier, France). Telenzepine (0.3 mg/kg) was dissolved with 0.9% sterile NaCl and administered intraperitoneally (i.p.) in a volume of 10 ml/kg, 30 min before behavioural tests to cover the period of maximal drug effect (Aliane, Pérez, Bohren, Deniau, & Kemel, 2011; Francardo et al., 2011 ).
| Behavioural tests
A battery of tests assessing cognitive and emotional impairment was performed after surgery in the different groups. All behavioural testing was carried out in dim light (8) (9) (10) (11) (12) during the light cycle. Sessions were recorded and analysed using a video-tracking software (Viewpoint Life Sciences, Lyon, France). Scoring was done offline by an investigator blind to the treatment. For each experiment, locomotor activity was measured by the total distance covered in the apparatus (open field or maze) during the testing period. A mouse that spends an inordinate amount of time (at least 50% of the 5-min test period) vigorously grooming was excluded from data analysis. Equipment was cleaned with a damp cloth between mouse trials.
| Elevated plus maze (EPM)
The elevated plus maze was performed to assess anxietyrelated behaviour. 
| Social interaction (SI)
Short-term social memory was evaluated with the social interaction test (Kalkonde et al., 2011) . Adult mice were habituated for 30 min to the testing room prior to the beginning of the experiment. Adult mice were then allowed to habituate for 10 min to an open field arena (50 × 50 cm with a 30 cmhigh white plastic wall) containing a small cage with stainless steel railings (8 × 8 × 10 cm-high) in its centre. After placing the juvenile (18-21 days old) in the small cage, the time and the number of adult-initiated contacts with the juvenile were recorded for 4 min. At the end of the first presentation (P1), the adult mice was removed from the open field, kept in an individual cage for a 30 min-delay period and then reexposed to the same juvenile for 4 min (second presentation, P2). Mice re-exposed to the same juvenile 30 min after an initial exposure display a little investigatory behaviour, reflecting an active recognition (Kalkonde et al., 2011) . Minimum exploration time of juvenile during P1 was set to 5 s, and mice that did not reach this criterion were excluded from data analysis. Data are expressed as a ratio of the duration of contacts (in sec) and number of contacts towards the same juvenile during P2 to P1.
| Object recognition (RO)
Spatial memory and non-spatial novelty memory were assessed according to the object recognition test previously described (Beer, Chwieśko, & Sauvage, 2014) . On the first day, mice were habituated to an open field arena (50 × 50 cm with a 30 cm-high white plastic wall) surrounded by a distal cue (double red stripe), for 30 min. The following day, mice were tested for their reaction to spatial or non-spatial memory of objects. The test procedure included an acquisition phase (10 min), a 30-min-delay period where mice returned to their home cages, and a recognition phase (10 min). During the acquisition phase, animals were exposed to two identical objects (falcon tissue culture flask filled with sand) placed in the northwest (NW; object A) and northeast (NE; object B) corner of the open field. In the spatial memory test (SRO), in the recognition phase, object A was placed at the same location (NW) while object B was placed at a different location (southeast SE) than experienced during the acquisition phase. In the non-spatial novelty test (NSRO), the two objects were placed at the exact same positions than in the acquisition phase, while object A was identical to that tested in the acquisition phase and placed in the NW corner, object B (plastic tower) was novel and placed in the NE corner. Active recognition was assessed by using the natural preference of rodents for novel object compared to familiar object. Accordingly, mice that successfully recognised one familiar item (e.g., previously experienced during the acquisition phase) should spend more time exploring the novel item than the familiar one. Spatial test and non-spatial novelty test were counterbalanced across animals and conditions. After each trial, the open field and objects were cleaned with a 10% ethanol solution. Minimum exploration time of objects A and B during the acquisition phase (T 1 A and T 1 B respectively) was set to 2 s, and mice that did not reach this criterion were excluded from data analysis. The time spent exploring each object during the recognition phase (T 2 A and T 2 B respectively) was recorded. The recognition index was defined as (T 2 B/(T 2 A + T 2 B) × 100). A recognition index of 50% corresponds to chance level whereas a higher recognition index reflects active recognition.
| Experimental design
| Optogenetic experiments
A first cohort of eNpHR transgenic mice (n = 29) received striatal 6-OHDA (n = 18) or vehicle injections (sham n = 11) and were bilaterally implanted with optical fibres as previously described. After a recovery period of 2 weeks, mice were tested in the EPM and the SI tests during optogenetic photoinhibition of ChIs. The two laser ON or OFF sessions were tested in the same animals in a counterbalanced manner interspaced by at least 8 days. Laser illumination was applied during the 5-min test period of the EPM and during the 4-min presentation of the juvenile on P2 of the SI test. A second cohort of eNpHR transgenic lesioned (n = 23) or sham-treated (n = 14) mice, implanted with bilateral optic
fibres in the striatum, were first tested for reversal learning in an operant nose-poke task (unpublished data) and then tested in the object recognition task 10 weeks post-lesion to assess the long-term effect of dopaminergic lesions. They were randomly assigned to one of the two lesioned groups or two sham-treated groups according to laser condition ON or OFF: [sham-laser OFF (n = 7), sham-laser ON (n = 7), 6-OHDA-laser OFF (n = 10) and 6-OHDA-laser ON (n = 13)] and were tested either in the spatial condition followed 1 week later by the non-spatial object recognition condition or in the inverse order. Laser photoillumination was applied during the recognition phase of the test (10 min) to assess memory retention.
| Pharmacological experiments
Two cohorts of mice were tested in the same behavioural tests to evaluate the effects of M1 muscarinic receptor blockade by i.p. injections of telenzepine 0.3 mg/kg. This dose of telenzepine was chosen because of its lack of effects in sham animals in a previous study. Telenzepine 0.3 mg/kg was also found to reverse the motor deficits produced by unilateral 6-OHDA lesions (Ztaou et al., 2016) . Sham (n = 19) and 6-OHDA (n = 15) operated mice were tested between days 13-33 post-surgery once in the EPM and in the SI tests. Another group of sham (n = 18) and 6-OHDA (n = 22) mice were tested in the spatial and non-spatial recognition tasks in a random order. Telenzepine or vehicle was injected i.p. in all mice 30 min before either the elevated plus maze, the second presentation of social interaction test or the recognition phase of object recognition.
| Immunolabelling and histology
Animals were deeply anesthetised with pentobarbital (100 mg/kg) and then transcardially perfused with an icecold solution of paraformaldehyde 4% in PBS. After dissection, brains were post-fixed overnight in the same fixative at 4°C, cryoprotected in 30% sucrose dissolved in 1X PBS for an additional 36 hr at 4°C and frozen. Coronal brain sections (40 μm) covering the anteroposterior extent of the substantia nigra pars compacta (SNc) and striatum were collected at −20°C with a Leica CM3050 S cryostat (Leica Microsystemes SAS, Nanterre, France) and kept free floating or mounted on superfrost plus slides depending on the experiment (immunostaining or Nissl staining on alternate sections). The dorsal hippocampus is long known to underlie visuospatial memory processes from the work of Olton et al. (Wible, Shiber, & Olton, 1992) and more recently by Bonito-Oliva, Masini, & Fisone, 2014), we thus evaluated if the partial lesion of the dopaminergic SNc neurons could impact dorsal hippocampus DA innervation. Coronal brain sections were thus also taken at the level of the dentate gyrus and processed for tyrosine hydroxylase (TH) immunostaining.
| TH immunostaining
Tyrosine hydroxylase immunostaining was performed in a selected group of sham and 6-OHDA-lesioned animals at completion of the behavioural testing. Brain sections were permeabilised in phosphate buffer (PBS) with 0.4% Triton X-100 (PBST) for 30 min at room temperature. Sections were then incubated in a blocking solution composed of PBST with 3% bovine serum albumin and 10% normal goat serum for 1 hr at room temperature. Sections were incubated overnight at 4°C in mouse anti-tyrosine hydroxylase (TH; 1/1,000, Millipore, AB318). They were then incubated in Alexa Fluor 594 goat anti-mouse (1/500, Invitrogen, A11005). Immunostaining was done on free-floating sections, which were then mounted onto SuperFrost Plus glass slides (VWR) and coverslipped with FluorSave mounting media (Merck Chemicals). Four to six images of TH-immunostained alternated slices from each animal were acquired on a fluorescence microscope (Leitz Aristoplan light microscope) equipped with a Nikon high resolution digital camera (756 × 581 pixels; Nikon, Tokyo, Japan) with a 10× objective, interfaced to a PC computer and Image software (Lucia, Nikon). The number of THpositive DAergic neurons in SNc was quantified in sections taken from −2.80 to −3.80 from bregma in a first group of selected subjects of behaving mice (sham n = 3, 6-OHDA n = 11, Figure 1a ,c). Slices were chosen to cover the entire rostral to caudal extension of the SNc. TH-positive cells in the SNc were counted manually in four regions of interest (ROIs, 1,100 × 1,100 μm) per hemisphere, using the cell counter plugin of FIJI software (ImageJ, National Institutes of Health). ROIs were determined to cover the whole mediolateral extension of the structure based on the stereotaxic mouse atlas (Paxinos & Franklin, 2001) . Cell number was calculated as the mean number/ROI. To detect potential loss of DA innervation of the dorsal hippocampus, TH staining intensity was also determined at the level of dentate gyrus (from anteriority level −1.34 to −2.18 from bregma) in two ROIs (3,000 × 3,000 μm) per hemisphere, using Image J software to evaluate the loss of catecholaminergic fibres. Quantification of TH immunostaining in the striatum, without tissue damage due to optic fibres implantation, was performed in an additional group of mice which received the same lesion procedure but were not evaluated behaviourally (sham n = 10, 6-OHDA n = 12, Figure 1d ). The extent of DA lesion in the striatum was expressed by the percentage of TH immunoreactivity of sham animals in the different structures. In this group, TH immunostaining was also measured in the SNc and dorsal hippocampus and the values compared to those obtained in the preceding group. TH immunoreactivity was calculated as the mean intensity value/ROI. In all cases, TH background was determined in the cortex of the same slice with three measures of the optical density that were then averaged for background subtraction. Each image and background-based thresholds were applied before analysis to account for small variances in the background between different slices and animals.
| Opsin and ChIs immunostaining
In transgenic Rosa eNpHR/+ ::ChAT cre/+ mice, issued by crossing the LoxP-stop-eNpHR3.0-EYFP line (Ai39 mice) with the ChAT cre/cre knock-in line, we controlled that the opsin (eNpHR3.0) was indeed correctly expressed in cholinergic neurons. Co-expression of eNpHR tagged with the fluorophore EYFP and ChAT was determined at the level of the striatum and the number of neurons was counted in striatal coronal sections of two mice. Brain sections of the striatum were permeabilised in PBST for 30 min at room temperature. Sections were then incubated in a blocking solution composed of PBST with 3% bovine serum albumin and 10% normal goat serum for 1 hr at room temperature. Brain sections were incubated overnight at 4°C in rabbit anti-GFP (1/500, Invitrogen, A11122) and goat anti-ChAT (1/100, Millipore, AB144P) for primary antibody exposure. They were then incubated, in Alexa Fluor 488 donkey anti-rabbit (1/500, Invitrogen, A21206) and Alexa Fluor 555 donkey anti-goat (1/500, Invitrogen, A21432) for 1 hr 30 at room temperature. Examination of eNpHR-EYFP in ChAT-expressing neurons was performed in the striatum from bregma +1.54 to −4.04 mm using confocal imaging with a Zeiss LM 710 NLO laser-scanning microscope equipped with a 63x/1.32 numerical aperture (NA) oil-immersion lens.
| Control of optic fibres implantation
Alternate sections (40 μm) were processed for Nissl staining with cresyl violet to check the placement of optic fibres in each striatum and assess possible tissue damage. Reconstitution of the implantation sites was determined in serial coronal sections and reported in schematic photomicrographs taken from the atlas of Paxinos and Franklin (2001) . Mice with incorrect placements or incomplete DA lesions were discarded from statistical analysis.
| Statistical analysis
All behavioural analyses were conducted on littermates and the values are presented as mean ± standard error of the mean (SEM). Immunofluorescence experiments. The effect of 6-OHDA lesion in each structure was analysed using Student's t test. Optogenetic experiments. Effects of 6-OHDA lesion and optogenetic photoinhibition were tested by two-way repeated-measures ANOVA (for elevated plus maze and social interaction tests) or two-way ANOVA (for spatial and non-spatial recognitions tasks) with groups (6-OHDA vs. sham) as between factor and laser (ON vs. OFF) as within factor, followed by adapted post-hoc tests between groups (Bonferroni's multiple comparisons test). Pharmacological experiments. Effects of 6-OHDA lesion and telenzepine treatment were analysed by two-way ANOVA, with groups (6-OHDA vs. sham) as between factor and pharmacological treatment (telenzepine vs. vehicle) as within factor, followed by adapted post-hoc tests between groups (Bonferroni's multiple comparisons test). Values of p < 0.05 were considered as significant for all analyses. Statistical analyses were performed using Prism6 (GraphPad software Inc., La Jolla, USA).
| RESULTS
| Effects of bilateral striatal 6-OHDA lesions on TH immunoreactive neurons
Bilateral 6-OHDA infusions in the dorsal striatum, quantified in a group of 11 lesioned and three sham mice, induced a partial loss of TH immuno-positive cells at different anteriority levels of the substantia nigra pars compacta (SNc) sparing the ventral tegmental area (VTA), as illustrated in Figure 1a . We expanded our examination of striatal 6-OHDA-induced DA denervation at the level of the striatum in an additional group of mice that were not implanted with optic fibres in the striatum. 6-OHDA lesions induced a partial loss of TH immunofluorescence extending in the rostro-caudal extent but not in the ventral striatum (Figure 1b) . In this group, TH-positive cells decreased to 47.5% (range 30%-70%) in the SNc compared to sham mice (Student's t test, t 16 = 3.35, p = 0.004, Figure 1c ) and TH immunoreactivity in the striatum was decreased to a level of 40% of control animals (Student's t test, t 20 = 3.66, p = 0.002, Figure 1d) . Correlation between the level of expression of TH immunoreactivity in the striatum and the loss of TH-positive cells in the SNc could be measured in 10 lesioned subjects with a similar number of slices taken in the two structures. Statistical analysis revealed a strong correlation (Pearson's r = 0.71, p = 0.02; Figure 1e) . A similar decrease of TH-positive cells averaging 53% (range 35%-70%) in the SNc was found in the first group of lesioned mice (Student's t test, t 12 = 4.32, p = 0.001, not illustrated).
At the level of the dorsal hippocampus, TH immunostaining tended to be reduced in 6-OHDA groups, although it did not reach significant level whatever the group (Student's t test, t 12 = 0.86, p = 0.4, and t 10 = 1.40, p = 0.19 respectively, not illustrated). These partial striatal DA depletion did not induce any major motor disabilities, contrary to the total unilateral nigrostriatal DA lesion as previously described. Consistent with that, the spontaneous locomotor activity measured in each behavioural test was not different between sham and 6-OHDA groups (See Table 1 ).
| Opsin eNpHR-expression in the striatum of transgenic mice
Transgenic lines of Rosa eNpHR/+ (Ai39 mice) conditionally express the Halorhodopsin/EYFP fusion protein from the endogenous Gt(ROSA)26Sor locus. Crossing Ai39 mice with ChAT cre/cre knock-in mice induces eNpHR3.0/ EYFP expression in cholinergic neurons throughout the brain (Vandecasteele et al., 2014) . We measured the co-expression of eNpHR-EYFP and ChAT at the level of the striatum in a selected number of transgenic Rosa eNpHR/+ ::ChAT cre/+ mice (transgenic eNpHR mice, n = 2) to control for the correct expression of the opsin (eNpHR) in cholinergic interneurons. In these transgenic mice, over 94% of striatal neurons expressing the eNpHR-EYFP opsin were identified as ChAT-expressing neurons (93.8% and 96.2% in n = 122 and n = 156 neurons in two mice, Figure 2a) . We have previously shown by recording identified ChIs, in vitro in striatal slices and in vivo anesthetised eNpHR transgenic mice, that the opsin was functional after laser illumination. In vivo, yellow laser (589 nm) continuous illumination of striatal ChIs for up to 3 min led to reversible photoinhibition of action potential firing activity in ChIs (Maurice et al., 2015; Ztaou et al., 2016) . Figure 2b shows schematic reconstructions of optical fibre illumination sites in the dorsal striatum at different anteriority levels, from +0.74 to +0.14 mm related to bregma. Nissl Cresyl violet staining shows the locations of the optic fibres on coronal sections at the level of striatum of representative subjects. There was no obvious tissue damage caused by relatively long period of light illumination as illustrated in a Nissl-stained section (Figure 2b ). Optical fibres were localised in the medial part of the dorsal striatum. Subjects with incorrect placement sites located outside the dorsal striatum were excluded from statistical analysis.
| Photoinhibition of striatal ChIs activity reverses non-motor parkinsonianlike symptoms
We examined the impact of optogenetic photoinhibition of striatal ChIs on several behavioural tests indexing anxietylike behaviour and memory deficits induced by partial nigrostriatal DA lesions. To evaluate anxiety-like behaviour, sham and 6-OHDA transgenic eNpHR mice were tested in the elevated plus maze after laser illumination (ON) and in OFF conditions. There was no difference of the order of photollumination (laser ON first and laser OFF or the opposite condition) on mice performance in the EPM or the SI. Two-way repeated-measures ANOVA revealed a significant lesion × laser interaction on the time spent, distance travelled, and number of entries in open arms (Figure 3a Notes. Global locomotor activity represents the total distance covered in each apparatus measured in cm (mean ± SEM) during the testing period of the elevated plus maze, social interaction, spatial and non-spatial object recognition experiments. Two-way ANOVA with groups (6-OHDA vs. sham) as between factor and pharmacological treatment (treatment vs. vehicle) as within factor showed no significant difference of global locomotor activity in the maze or open field. 6-OHDA: 6-hydroxydopamine; ANOVA: analysis of variance; P1: first presentation; P2: second presentation. between groups (F 1,19 = 2.47, p = 0.13; Table 1 ), showing that the anxiolytic-like phenotype produced by a partial 6-OHDA lesion was not produced by a reduction of motor activity. The photoinhibition of striatal ChIs did not modify the global exploratory behaviour either in control or 6-OHDA-lesioned mice.
To investigate short-term social memory in 6-OHDA-lesioned mice, we tested the ability of adult mice to recognise a juvenile congener after a second exposure interspaced by a 30-min interval, illustrated by videotracking paths of the mice towards the centre of the openfield, where the juvenile is placed under a grid (Figure 3b ). Data were analysed as a ratio of the contacts duration and number of contacts towards the juvenile congener between the second presentation (P2) and the first presentation (P1). A low ratio indicated that the juvenile was recognised at the second presentation. Two-way repeated-measures ANOVA revealed a significant lesion × laser interaction on the ratio comparing the contacts durations and number of contacts during P2 to P1 (contacts duration: F 1,18 = 11.69, p = 0.003; number of contacts: F 1,18 = 4.29, p = 0.05). In comparison with sham, 6-OHDA mice clearly did not identify the juvenile, as found by a significant increase of the ratio P2/P1 (Figure 3b ; Bonferroni's test, p < 0.0001 and p = 0.003 respectively). Photoinhibition of striatal ChIs in 6-OHDA Table 1 ).
We then carried out further experiments to assess the role of striatal ChIs on visuospatial memory and novel object recognition processing. The videotracking of the paths and manual counting offline of sham animals revealed an active object recognition in the spatial (Figure 3c ) and non-spatial (Figure 3d) versions of the task. There was no difference in | ZTAOU eT Al.
the time spent investigating the displaced or novel objects whether mice were tested first in the SRO or in NSRO conditions. Two-way ANOVA showed a significant lesion × laser interaction on recognition index in the spatial recognition task (Figure 3c ; F 1,32 = 8.33, p = 0.006). 6-OHDA-lesioned mice spent a similar amount of time investigating the familiar or displaced object as shown by a significant decrease of the recognition index (Bonferroni's test, p = 0.0007). Photoinhibition of striatal ChIs in 6-OHDA mice significantly restored the recognition index (Bonferroni's test, laser ON vs. OFF, p = 0.002) without affecting global locomotor activity (F 1,32 = 2.61, p = 0.11; Table 1 ). Interestingly, no effect of either 6-OHDA lesion or photoinhibition of striatal ChIs was observed in the non-spatial recognition task (Figure 3d ; F 1,32 = 0.006, p = 0.93) indicating that 6-OHDA lesion only impaired the spatial discrimination but not the novelty detection.
| M1 mACh receptor blockade restores control level of anxiety and social interaction
Muscarinic cholinergic receptor subtypes M1 are highly expressed in the striatum (Bonsi et al., 2011) and the pharmacological blockade with a preferential M1 mACh receptor antagonist, telenzepine at a dose of 0.3 mg/kg, was previously found to reverse motor impairment in the unilateral 6-OHDA model of PD (Ztaou et al., 2016) . To study whether M1 mACh receptor blockade could also be beneficial in restoring emotional and cognitive functions, injections of telenzepine 0.3 mg/kg i.p. were tested in another group of sham and 6-OHDA-lesioned mice. In the EPM, a two-way ANOVA re- In the SI test, two-way ANOVA revealed a significant lesion × treatment interaction on the ratio comparing the contacts durations and number of contacts during P2 to P1 (contacts duration: F 1,30 = 10.47, p = 0.003; number of contacts: F 1,30 = 7.62, p = 0.009). In comparison with sham, 6-OHDA mice did not identify the juvenile, as found by a significant increase of the ratio P2/P1 (Bonferroni's test, p = 0.0004 and p = 0.003 respectively; Figure 4b ). Intraperitoneal injection of telenzepine in 6-OHDA mice significantly restored the recognition of the juvenile (Bonferroni's test, 0.3 vs. 0 mg/kg, contacts duration: p = 0.0008; number of contacts: p = 0.006). No significant difference of locomotor activity in the open field was found between the two presentations and between groups (F 3,30 = 0.29, p = 0.84; Table 1 ).
Visuospatial memory deficits and novelty detection were then assessed after telenzepine i.p. injection. Twoway ANOVA revealed no significant lesion × treatment interaction on recognition index in the SRO task (Figure 4c ; F 1,38 = 0.83, p = 0.37) but a significant main effect of lesion (F 1,38 = 122.20, p < 0.0001) and no effect of telenzepine treatment (F 1,38 = 2.25, p = 0.14). Global locomotor activity was not affected by 6-OHDA or telenzepine treatment in the SRO task (F 1,38 = 0.58, p = 0.45) . No effect of either 6-OHDA lesion or telenzepine treatment was observed in the NSRO task (Figure 4d ; F 1,36 = 1.38, p = 0.25) and in locomotor activity (F 1,36 = 0.04, p = 0.85).
| DISCUSSION
Cholinergic interneurons play a crucial role in the regulation of striatal functions and in the pathophysiology of basal ganglia disorders. In the present study, we used optogenetic photoinhibition of striatal ChIs in mice with mild dopamine (DA) depletion of the striatum mimicking a prodromal stage of PD to assess their role in non-motor dysfunctions of Parkinson's disease (PD). Our results show that striatal ChIs photoinhibition reduces anxiety, short-term social and spatial memory impairment of 6-OHDA-lesioned mice. Telenzepine, a muscarinic M1 receptor antagonist, injected peripherally diminishes the anxiety level and restores the recognition of the juvenile in the social interaction test, without affecting visuospatial memory impairment.
| Partial 6-OHDA nigrostriatal lesions disrupt emotional and cognitive processes
Early cognitive deficits and mood disorders precede the hallmark motor symptoms of PD patients, do not respond well to dopamine therapy and impact deeply the quality of life. Therefore, animal models of prodromal stage of the disease may help to find new pharmacologic targets for palliative and neuroprotective treatments. As previously found in mice (Bonito-Oliva et al., 2014; De Leonibus et al., 2007) , the neurotoxin 6-OHDA injected at low concentration in the dorsal striatum induces a retrograde neurodegeneration of DA neurons in the SNc averaging 53% loss of TH-positive cells. These levels of DA cell loss can be reproduced in different groups of mice as found here associated with a partial decrease | ZTAOU eT Al.
(40%) of TH immunoreactivity in the striatum. In a previous study, using biochemical analysis ex vivo of tissue levels of DA and its metabolites in sham and 6-OHDA-lesioned mice, we found a positive correlation between the visuospatial deficits in the spatial object recognition task and the tissue levels of dopamine within the dorsal striatum. The less dopamine in the dorsal striatum the worst was the deficit in detecting spatial changes (De Leonibus et al., 2007) . Furthermore, we demonstrated that variable behavioural traits affecting akinetic or attentional and cognitive processes could be related to the extent of DA depletion in rats with partial striatal 6-OHDA lesions (Amalric, Moukhles, Nieoullon, & Daszuta, 1995; Mourre et al., 2017) . A variability in the extent of DA lesions within animals of each group is also found in other models of early PD, such as the α-synuclein models in mice transgenic for truncated human α-synuclein, which shows no loss of nigral DA neurons but a progressive decreased level of striatal DA accounting for plasticity changes in ChIs (Magen & Chesselet, 2010; Tozzi et al., 2016) . Here, we found that partial 6-OHDA lesions may have long-lasting cognitive deficits as shown by the impairment of object recognition in a subgroup of mice tested 10 weeks post-lesion in the spatial version of the object recognition.
Despite the variability of the striatal 6-OHDA lesions, they induced profound short-term memory impairment in social investigation of the juvenile and spatial object recognition. Interestingly, the novel object was recognised by the lesioned mice suggesting that their ability to discriminate a novel object from a familiar one was not impaired nor due to a diminished exploratory behaviour. Cognitive symptoms in PD patients include deficits in visuospatial discrimination, working memory, attention processes and flexibility which can be related to both striatal and prefrontal dysfunction (Chaudhuri et al., 2006 (Chaudhuri et al., , 2011 Owen et al., 1993) . In addition, the increased level of anxiety-like behaviour observed in our 6-OHDA-lesioned mice in the elevated plus maze may be related to the anxiety disorders that are seen in a considerable percentage of parkinsonian patients well before the motor symptoms are evident (Chaudhuri et al., 2006 (Chaudhuri et al., , 2011 Meissner, 2012) . There was no change in total time spent in the elevated plus maze compared to controls, nor in the total distance travelled in the open field demonstrating that the behavioural deficits were not secondary to motor impairment.
| Contribution of striatal cholinergic interneurons to cognitive impairment and anxiety in a prodromal model of PD
The imbalance between ACh and DA activity in the striatum is central to the development of motor symptoms of PD (Calabresi, Picconi, Parnetti, & Di Filippo, 2006; Pisani et al., 2007) . Whether the activity of the striatal cholinergic system is also affected by a mild nigrostriatal DA denervation, when motor symptoms are not manifest, is largely unknown. We thus first verified that ChIs photoinhibition did not alter the exploratory behaviour of mice while performing tests. Silencing ChIs did not affect the locomotion activity in the three different tests. ChIs selective elimination by immunotoxin-mediated cell targeting in the dorsomedial striatum had no effect on locomotion either (Okada et al., 2014) . ChIs photoinhibition did not produce any memory impairment nor changes in anxiety level in controls (sham-operated mice), suggesting that the laser light by itself did not produce any uncontrolled effect. In our transgenic mice, the co-expression of eNpHR-EYFP and ChAT was present in most of ChIs (over 94% overlay) at the level of the striatum ruling out the possibility that the laser light would not affect the opsins. The continuous photoillumination conditions for 5-10 min, depending on the test, has been previously found to cause no physical damage to the brain tissue (Gradinaru, Mogri, Thompson, Henderson, & Deisseroth, 2009; Yizhar, Fenno, Davidson, Mogri, & Deisseroth, 2011) . As previously demonstrated, the laser power levels were sufficient to inhibit neuronal activity without causing adverse effects. In fact, a continuous light stimulation of 5-min duration significantly alleviated motor deficits in the extensive model of PD while a 3-min photoillumination of striatal cholinergic neuronal activity in anesthetised mice was found to inhibit action potentials in the striatum in a reversible manner (Ztaou et al., 2016) . Furthermore, ChIs photoinhibition did not modify the membrane excitability of striatal medium spiny neurons (MSNs) in sham animals (Maurice et al., 2015) . Optogenetic inhibition of ChIs in sham-operated mice did not affect recall memory nor learning, did we therefore apply ChIs photoinhibition in the recall phase of spatial memory that was disrupted by partial 6-OHDA lesions. In 6-OHDA-lesioned mice, photoinhibition of striatal ChIs fully reversed visuospatial discrimination, social recognition impairment, and anxiety-like behaviour. The beneficial effects of silencing ChIs on short-term memory processes and anxiety phenotype may be directly linked to the reduction of the pathological increased striatal cholinergic tone in the core of the lesion and the resulting changes in ChIs excitability, although this remains to be demonstrated. We indeed aimed at illuminating the dorsal and medial part of the striatum (DMS) as illustrated in Figure 2b , close to the core of the bilateral 6-OHDA infusions in the dorsal part of the striatum. The restricted 6-OHDA infusion in the striatum is likely to produce a gradient in the lesioned area. The loss of DA fibres within the core of the lesion could result in an increased cholinergic tone disrupting shortterm memory processes; however, the restricted striatal DA denervation would not alter motor activity. In addition, the role that striatal cholinergic activity plays in new learning and synaptic plasticity depends on the posterior DMS (Bradfield et al., 2013) . Changes of synaptic plasticity appear to depend on cholinergic tone (Hasselmo & Bower, 1993; Ragozzino, Mohler, Prior, Palencia, & Rozman, 2009) , therefore transiently suppressing cholinergic activity locally in the striatum may restore the control level of ACh enabling recognition of familiar animal or object in the social interaction and spatial version of the object recognition. Other mechanisms might be involved in a model of early PD, such as the impairment of long-term potentiation (LTP) in striatal ChIs (but not in MSNs) produced by overexpression of wild-type human α-synuclein in the rat SNc (Tozzi et al., 2016) . The partial reduction of striatal DA level is associated with reduced cognitive performance in an active avoidance test, supporting the view that the loss of synaptic plasticity in ChIs may represent a precocious marker of cognitive dysfunction in PD (Tozzi et al., 2016) .
Silencing ChIs could act through different mechanisms to restore or partially mimic the pause of ChI firing well known in the literature to be crucial for learning processes, which happened to be disrupted by the 6-OHDA lesion (Aosaki, Graybiel, & Kimura, 1994; Aosaki, Miura, Suzuki, Nishimura, & Masuda, 2010) . In addition to the striatal dopaminergic dysfunction, other pathological features may generate hippocampal-dependent memory deficits in PD (Churchyard & Lees, 1997) . Reduction in TH immunoreactivity in the hippocampus, produced by striatal 6-OHDA lesions, disrupts LTP in the dentate gyrus and impair long-term object memory recognition (Bonito-Oliva et al., 2014) . There was a non-significant reduction in TH immunoreactivity in the dorsal hippocampus in the present model of early PD that could not account alone for the visuospatial and discriminatory memory deficits. Furthermore, striatal ChIs photoinhibition fully restored short-term memory recognition, pointing to a critical role of ChIs of the striatum in these processes.
| Modulation of M1 muscarinic cholinergic receptors reverses nonmotor deficits
Muscarinic cholinergic receptor subtypes M1 and M4 have a predominant expression in the striatum as compared with M2 and M3 subtypes (Bonsi et al., 2011) . Here, we found that the systemic injection of the M1 mAChR preferential antagonist telenzepine is anxiolytic and restores an efficient recognition in the social interaction that was disrupted in partially DAdepleted mice. In humans, studies reported cognitive deficits in parkinsonian patients in advanced stages-likely described as frontal lobe deficits due to a direct consequence of impaired mesocortical dopaminergic transmission-when treated by non-selective mAChR antagonists such as scopolamine (Langmead et al., 2008; Müller & Bohnen, 2013) . The lack of selectivity of pharmacological compounds makes the interpretation of mechanism of action unclear. Newman and Gold (2016) showed that the cholinergic tone that is too low or too high is related to poor cognitive functions, depending on the task. In their study, scopolamine alters memory processes by acting on postsynaptic mAChRs. But it also acts on presynaptic M2 mAChRs, thus increasing the release of ACh, and accordingly improves memory processes (Newman & Gold, 2016) . In the present study, the lack of effect of telenzepine in reversing spatial memory impairment (in comparison with social memory recognition) could result from these puzzling effects.
Telenzepine, at a dose of 0.3 mg/kg, does not disrupt anxiety level, object, or social recognition of sham animals, unlike other non-selective cholinergic antagonists such as scopolamine which are known to alter memory processes at high concentration. In fact, the beneficial effects of telenzepine at this low concentration are only observed here after the degeneration of the nigrostriatal DA pathway producing an imbalance between ACh and DA activity in the striatum. The disruption of the DA/ACh balance was found to be crucial in the ventral striatum where an enhanced activation of ACh in the nucleus accumbens shell generate a variety of aversive behaviours, including depression, anhedonia, and anxiety (Chen, Rada, Bützler, Leibowitz, & Hoebel, 2012) . The results obtained with telenzepine suggest that increased cholinergic activity in the striatum may underlie the anxiety-like behaviour produced by partial 6-OHDA lesions. We cannot neglect that systemic injection of telenzepine targets also M1 mAChRs located in others brain areas. Indeed, the hippocampus-structure wellknown to be implicated in memory processes-expressed mainly M1 receptors (36% in comparison to other mAChRs; Volpicelli & Levey, 2004) . The lack of effect of systemic telenzepine on spatial recognition might thus be due to an opposite action of telenzepine in the striatum and the hippocampus.
In conclusion, while decreasing cholinergic signalling rescue the motor dysfunctions seen with PD in the late stage of the disease, this study shows that the critical DA/ ACh imbalance may also underlie the short-term memory dysfunction observed in the early phase of the disease. Systemic blockade of M1 mAChRs improves anxiety behaviour-like and short-term memory in the prodromal mice model of PD; however, its effect on memory processes (a) is dependent upon an optimal level of ACh release, and (b) seems not to be due to a specific action in the striatum. Moreover, our study focus on M1 mAChRs, one of the subtypes highly expressed in the striatum (Conti, Chambers, & Bishop, 2018) . We however cannot neglect that ChIs activity is also driven on nicotinic receptors which contributes to elevate the striatal DA release (Threlfell & Cragg, 2011; Threlfell et al., 2012) .
